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The iron-specific magnetic susceptibility of tissue iron deposits is used in the field of non-invasive measurement of tissue iron concentrations.
It has generally been assumed to be a constant for all tissue and disease types. The iron-specific magnetic susceptibilities χFe for spleen tissue
samples from 7 transfusion dependent β-thalassaemia (β-thal) patients and 11 non-transfusion dependent β-thalassaemia/Haemoglobin E (β/E)
patients were measured at 37 °C. Both groups of patients were iron loaded with no significant difference in the distribution of spleen iron
concentrations between the two groups. There was a significant difference between the mean χFe of the spleen tissue from each group. The non-
transfusion dependent β/E patients had a higher mean (±standard deviation) spleen χFe (1.55±0.23×10
−6 m3/kg Fe) than the transfusion
dependent β-thal patients (1.16±0.25×10−6 m3/kg Fe). Correlations were observed between χFe of the spleen tissue and the fraction of magnetic
hyperfine split sextet in the 57Fe Mössbauer spectra of the tissues at 78 K (Spearman rank order correlation r=−0.54, p=0.03) and between χFe of
the spleen tissue and the fraction of doublet in the spectra at 5 K (r=0.58, p=0.02) indicating that χFe of the spleen tissue is related to the chemical
speciation of the iron deposits in the tissue.
© 2007 Elsevier B.V. All rights reserved.Keywords: Haemosiderin; Ferritin; Magnetic susceptibility; Thalassaemia; Iron1. Introduction
Iron overload is a condition that affects patients with
haemoglobinopathies who either require regular blood transfu-
sions [1] or have increased dietary iron absorption, and also
patients with various forms of hereditary hemochromatosis [2].
Measurement of tissue iron concentrations is a part of the
clinical management of many of these patients [3]. Liver iron
concentration (LIC) is considered to be a reliable indicator of
overall body iron burden. However, direct measurement of
LIC by chemical analysis of needle biopsy samples is
problematic both because of the sampling error introduced
by the small size of the sample obtained and because of the
associated morbidity and mortality risks associated with
biopsy [4–7]. Over the past two decades or so, non-invasive
methods of measurement of LIC have been developed whichAbbreviations: W–M–W, Wilcoxon–Mann–Whitney
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doi:10.1016/j.bbadis.2006.12.007exploit the large and positive magnetic susceptibility of tissue
iron deposits relative to the small and negative magnetic
susceptibility of the other components of body tissues [8–11].
The iron deposits in iron loaded tissue are predominantly in
the form of haemosiderin and ferritin [12]. Haemosiderin is an
insoluble pathological compound containing particles of
hydrated iron(III) oxyhydroxide associated with organic
components while ferritin is an iron storage and homeostasis
protein [13]. Ferritin is composed of 24 polypeptide subunits
that self assemble to form an approximately spherical shell-
like structure with an external diameter of approximately
12 nm and an internal cavity diameter of approximately 8 nm
[14]. Iron is stored within the cavity in the form of a particle of
hydrated iron(III) oxyhydroxide. Although both ferritin and
haemosiderin have an inorganic iron(III) oxyhydroxide
component, the chemical speciation of this component can
vary. Three different chemical species of tissue iron(III)
oxyhydroxide have been identified namely (i) ferrihydrite (a
poorly crystalline mineral with the approximate formula
5Fe2O3·9H2O, (ii) a mineral with a structure related to very
poorly crystalline goethite (goethite has the formula α-FeOOH),
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The chemical speciation of these iron(III) oxyhydroxides has
been shown to be different in different identifiable groups of
iron loaded patients [17]. Since different chemical speciation of
iron oxides is known to lead to different iron-specific magnetic
susceptibilities [18], a knowledge of the magnetic suscept-
ibilities of ferritins and the different forms of haemosiderin is
of practical importance in the field of non-invasive measure-
ment of tissue iron concentrations using methods such as
biomagnetic susceptometry and magnetic resonance imaging
that exploit the relatively large magnetic susceptibility of these
materials.
The magnetic susceptibilities of ferritin and haemosiderin
were first measured by Michaelis and coworkers [19]. They
made measurements on samples of horse spleen ferritin at
27 °C and haemosiderin at 22 °C yielding iron specific mag-
netic susceptibility values of 1.33 (±0.02)×10− 6 m3 /kgFe for
the ferritin and 1.1×10− 6 m3/kgFe for the haemosiderin. This
work was later followed by measurements at 23 °C on human
ferritin and haemosiderin isolated from liver tissue by Schoden
and Sturgeon [20] yielding values of 1.6×10−6 m3/kgFe for
the ferritin and values of 1.5, 2.1, and 1.2×10−6 m3/kgFe for
three different human haemosiderin samples. The value of
1.6×10−6 m3/kgFe for human ferritin measured by Schoden
and Sturgeon has subsequently been used by Fischer and
coworkers [21] to obtain non-invasive in vivo measurements of
liver iron concentrations in iron loaded patients using the
technique of magnetic biosusceptometry [22,23]. This value is
now routinely used in biosusceptometry measurements to
determine liver iron concentrations. However, the biological
variability in the magnetic susceptibility measurements of
Michaelis and coworkers [19] and Schoden and Sturgeon [20]
appears to be larger than their reported analytical variability
suggesting that the magnetic susceptibility of tissue iron
deposits may vary between individuals. Furthermore, since
the early measurements of the magnetic susceptibilities of
ferritin and haemosiderin, there has been the discovery that
there are different chemical species of iron(III) oxyhydroxide
associated with different samples of haemosiderin and that the
different chemical species have different magnetic properties at
cryogenic temperatures [13,16,24]. These observations raise the
questions of whether or not there are significant differences in
the body temperature magnetic susceptibilities of the different
chemical species of tissue iron deposit and to what degree these
differences might affect measurements of tissue iron concen-
tration by biomagnetic susceptometry techniques when differ-
ent species are present or when the chemical speciation is
unknown.
In order to address these questions, the iron specific
magnetic susceptibilities of iron loaded spleen tissues from
two identifiably different groups of iron-loaded patients have
been measured. Spleen tissue was chosen because it is readily
available after splenectomy procedures. The two groups of
patients have been shown in a previous study to have different
chemical speciation of the spleen tissue iron deposits [17]. The
characterisation of the chemical speciation of the iron in these
tissues is extended in this study.2. Materials and methods
All human tissue samples were obtained under Human Ethics Committee
guidelines (guidelines from human rights committees in both Australia and
Thailand). Samples of spleen were obtained from two identifiably different
groups of iron loaded patients, namely 7 β-thalassaemic patients who had
received regular red cell transfusions and iron chelation therapy and 11 β-
thalassaemia/haemoglobin E patients who had received few, if any, red cell
transfusions and no iron chelation therapy. These tissue samples have been
shown in a previous study to have different chemical speciation of tissue iron
deposits with the β-thalassaemic tissues having a greater fraction of the iron in
the form of goethite-like haemosiderin than the β-thalassaemia/Hb E samples
[17]. The β-thalassaemic samples were obtained from patients who had
undergone splenectomy at Princess Margaret Hospital, Perth. The ages of the
patients at the time of splenectomy ranged from 10 to 15 years and all had
received regular transfusions of packed red cells together with chelation therapy.
Regular transfusions of packed red cells (15–20 ml/kg body mass/month) were
started at about 12 months of age. This regimen is equivalent to a rate of
approximately 0.5 units of packed red cells per month at age 1 year increasing to
1–2 units of packed cells per month by the age of approximately 10 years.
Chelation therapy using desferrioxamine (Desferral, Ciba-Geigy) was started
between the ages of 2 and 3 years. Samples of β-thalassaemia/Hb E spleen were
obtained either post splenectomy or post mortem from 11 patients from Siriraj
Hospital, Bangkok. The age of the patients ranged from 20 to 40 years and they
had received few (less than a total of 30 units of packed red cells), if any, red cell
transfusions and no chelation therapy. Tissue samples were freeze dried and
ground to a powder prior to magnetic susceptometry measurements and iron
content analysis with atomic absorption spectrometry.
A sample of human liver ferritin was also prepared to enable comparison of
results with those on human liver ferritin measured by Schoden and Sturgeon
[20]. The ferritin was isolated from four livers obtained post-mortem from β-
thalassaemia/Hb E subjects according to the method of ferritin purification
described by Chua-anusorn and St. Pierre [25]. These subjects had received few,
if any, blood transfusions.
Mössbauer spectra were recorded in transmission geometry using a 57Co in
rhodium foil source. The source was driven at constant acceleration from −13 to
+13 mm/s with a double ramp waveform. Spectra were subsequently folded to
eliminate the parabolic background caused by variation in the solid angle
subtended by the detector window about the source. The resulting spectra
consisted of 250 data points with a background count of between approximately
1×106 and 2×106 per channel. The counting time was determined by the iron
concentration of the sample under study. The velocity scale was calibrated with
reference to the spectrum of an α-iron foil at room temperature, the centre of the
spectrum being taken as zero velocity. Freeze dried samples of tissue were
packed into 10 mm diameter Perspex sample holders for the 78 K spectra and
13 mm copper sample holders with Mylar windows for the 5 K measurements.
The thickness of the sample was adjusted so that the 14.4 keV Mössbauer γ rays
were attenuated by approximately 1/e. Sample temperatures were maintained at
78 K or at 5 K during the spectral data acquisition using a liquid nitrogen or
liquid helium cryostat respectively.
Each Mössbauer spectrum was initially fitted with a doublet and sextet of
Lorentzian peaks using a sum of squares minimization procedure. In some
spectra, a small signal owing to haem-iron was detectable and as such a second
doublet was included in the fitting procedure. The doublet from haem-iron is
clearly distinguishable from that of paramagnetic haemosiderin iron since it
exhibits a much larger quadrupole splitting giving a clearly resolved peak even
when superimposed on a paramagnetic haemosiderin doublet [26]. In such
cases, the relative spectral area of the haem doublet was used to measure the
fraction of haem-iron in the sample. The two peaks in each doublet were
constrained to be of equal area and width while the ratio of areas of the outer to
middle to inner pairs of peaks of the sextet were constrained to be in the ratio
3:2:1. The linewidths, centre shift, and quadrupole splitting of the doublet were
allowed to vary freely during the fits as were the linewidths, magnetic-
hyperfine-field splitting, centre shift, and quadrupole perturbation on the sextet.
This fitting procedure yields reproducible spectral parameters and doublet to
sextet area ratios for spectra with high signal to noise ratios. However, for some
of the 78-K spectra with low sextet-signal to noise ratios, this fitting procedure
tends to give unreliable results.
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in the 4 spleen spectra with the highest sextet-signal to noise ratio were used as a
standard with which to refit all of the spleen tissue 78-K spectra. All of the
spleen 78-K spectra were refitted with a high-spin Fe(III) doublet, a haem
doublet where necessary, and the standard sextet. During the fitting procedure,
the linewidths, magnetic-hyperfine-field splitting, centre shift, and quadrupole
perturbation of the sextet were allowed to vary by up to one standard deviation
from the mean values derived from the 4 spectra with the highest sextet-signal to
noise ratios. The area of the sextet was allowed to vary freely. In this way the
relative spectral area of the sextet in spectra with very low sextet-signal to noise
ratios could be more reliably assessed assuming that the Mössbauer spectral
parameters of the sextet do not vary significantly from sample to sample.
Samples of the freeze-dried powders (both tissues and ferritin sample) were
compressed into pellets of approximate mass 60 mg for magnetic susceptometry
measurements. All pellets were less than 4.5 mm in length. For three of the
spleens, duplicate pellets were made in order to test reproducibility of
measurements. Pellets were mounted in long uniform plastic tubes and were
held in place in the tubes for magnetometry measurements with plastic collars of
less than 8 mm in length that surrounded the pellets symmetrically. The tubes
were much longer than the dimensions of the sense coils and hence do not
contribute to the measured signal. However, the diamagnetic susceptibility of
the collars was measured independently and accounted for in the measurement
of the sample magnetic susceptibilities by subtraction of the moment of the
collar from the moment of the collar and pellet.
Magnetic susceptometry measurements were made using a Quantum Design
magnetic properties measurement system (MPMS-7). The instrument uses a
sensor based on a superconducting quantum interference device (SQUID) for
detection of sample magnetic moments as they are passed through a second-
order gradiometer superconducting sensor coil system. The sensor coil system
consists of a central coil with 2 counter-clockwise turns and 2 single clockwise
turn coils 2 cm above and 2 cm below the central coil. As both collars and
sample pellets were less than 10 mm in length they were small with respect to the
coil spacing and hence were approximated as point dipoles.
Sample magnetic moments were measured as a function of applied magnetic
field over the range of fields ±2.4×106 A/m (±30 kOe). Sample temperatures
were maintained at 37 °C during the measurements. At this temperature and over
this magnetic field range the magnetic moment of the samples was
approximately linear with applied magnetic field, consistent with previous
observations of magnetic susceptibility of ferritin at temperatures close to body
temperature [27,28]. Iron-specific magnetic susceptibilities were determined by
measuring the slope of the mass-specific magnetic moment against applied
magnetic field and correcting for collar magnetic susceptibility and iron-free-
tissue magnetic susceptibility (see Results).
Tissue samples were stored in the freeze dried state between measurement
of Mössbauer spectra and measurement of the magnetic susceptibility. In order
to check that no change in chemical speciation had occurred during the
intervening period, a Mössbauer spectrum was recorded for a second time at
78 K for a sample of spleen tissue with a mixture of spectral species after the
magnetic susceptibility measurement. No changes in the Mössbauer spectral
parameters were detectable indicating that there had been no detectable change
in the chemical speciation of iron within the sample during the period of the
study.Fig. 1. Mössbauer spectra from a sample of β-thalassaemia/Hb E spleen tissue
sample at (a) 78 K and (b) 5 K.3. Results
Elemental analysis of the tissue samples indicated tissue iron
concentrations ranging from 2.2 to 21 mg Fe g− 1 dry tissue. The
means (±standard deviation) of the non-haem iron concentra-
tion of the β-thalassaemic and β-thalassaemia/Hb E samples
were 7.7 (±6.3) and 5.6 (±1.9) mg/g dry tissue, and the medians
(and interquartile ranges) were 6.1 (3.6–8.9) and 5.7 (4.4–
9.3) mg/g dry tissue respectively. There was no significant
difference in the distribution of tissue iron concentrations
between the two groups of patients as determined by a
Wilcoxon–Mann–Whitney (W–M–W) test (p=0.93).3.1. Mössbauer Spectroscopy
Mössbauer spectra of the spleen tissue samples comprised a
superposition of a doublet spectral component (attributed to
paramagnetic or superparamagnetic high-spin iron(III)) and a
sextet spectral component (attributed to magnetically blocked
iron(III) ) at both 78 K and 5 K (see Fig. 1). For an explanation
of terms and physical principles related to the interpretation of
the Mössbauer spectra of tissue iron deposits, see St Pierre et al.
[13]. For some samples a small doublet attributable to haem iron
was also apparent (1 spleen from a transfusion dependent β-
thalassaemia patient showed a 20% haem doublet; 2 spleens
from non-transfusion dependent β-thalassaemia/Hb E patients
showed 6% and 1% haem doublets each; for all other samples a
haem doublet was not detectable). Mean values for the fitted
parameters of each spectral component are given in Table 1. The
fraction FS of the non-haem spectral signal in the form of a
sextet at 78 K is related to the fraction of non-haem tissue iron in
the form of the goethite-like iron oxyhydroxide [13,15,29]. The
Table 1
Mean values and standard deviations (or ranges) for Mössbauer spectral parameters of doublet and sextet components in thalassaemic tissues at 78 K and at 5 K
Spectral component δ (mm/s) ΔEQ (mm/s) Bhf (T) Γ (mm/s)
78 K Doublet 0.46±0.02 0.67±0.03 0.63±0.07
Sextet 0.47 (0.42 to 0.51) −0.21 (−0.28 to −0.13) 47.0 (46.5 to 47.4) 0.86 (0.73 to 0.99)
5 K Doublet 0.50±0.02 0.55±0.04 0.56±0.08
Sextet 0.47±0.04 −0.15±0.04 48.9±5.9 0.59±0.21
δ is the centre shift, ΔEQ is the quadrupole splitting or quadrupole perturbation of the doublet and sextet component respectively, Bhf is the magnetic hyperfine-field
splitting and Γ is the full linewidth at half-height. For the sextet component, Γ is measured from the outer peaks.
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fusion dependent β-thalassaemia patients was 0.27±0.12 and
from the non-transfusion dependent β-thalassaemia/Hb E
patients was 0.129±0.036. The medians (and interquartile
ranges) of FS were 0.26 (0.13–0.33) and 0.125 (0.102–0.243)
for the β-thalassaemia and β-thalassaemia/Hb E patients
respectively. The distributions of FS for the two patient groups
were significantly different (W–M–W test p=0.01) (Fig. 2).
The fraction FD of non-haem spectral signal in the form of a
doublet at 5 K is reported to be related to the fraction of tissue
non-haem-iron in the form of non-crystalline iron oxyhydroxide
[13,15,29]. The mean (±standard deviation) of FD for spleens
from the transfusion dependent β-thalassaemia patients was
0.22±0.08 and from the non-transfusion dependent β-thalas-
saemia/Hb E patients was 0.43±0.19. The medians (and
interquartile ranges) of FD were 0.26 (0.18–0.36) and 0.41
(0.25–0.59) for the β-thalassaemia and β-thalassaemia/Hb E
patients respectively. The distributions of FD for the two patient
groups were not found to be significantly different using a W–
M–W test. A statistically significant correlation was found
between FS and tissue non-haem-iron concentration but not
between FD and tissue non-haem-iron concentration. A weak
correlation was found between FS and FD (Spearman rank
order correlation coefficient 0.47, p=0.051). The relationship
between the two parameters appears non-linear (Fig. 3) with FSFig. 2. Scatter plot of FS, the fraction of Mössbauer spectrum recorded at 78 K in
the form of a sextet for β-thalassaemia (●) and β-thalassaemia/Hb E (▲) spleen
tissue samples.remaining at approximately 0.10 until FD drops below
approximately 0.35. As FD drops below 0.35 there is a very
rapid rise in FS to values around 0.40.
3.2. Magnetic susceptibility measurements
The mass-specific magnetic susceptibility, χMass, of each
tissue sample is shown plotted against tissue non-haem-iron
concentration in Fig. 4. The relationship between mass-specific
magnetic susceptibility and tissue non-haem-iron concentration
appears to be different for the two patient groups with the
transfusion-dependent β-thalassaemia patients exhibiting a
generally lower non-haem-iron-specific magnetic susceptibility,
χFe, than the non-transfusion-dependent β-thalassaemia/Hb E
patients. The mass-specific magnetic susceptibility and non-
haem-iron concentration data were fitted with the following
model, based on Weidemann's mixture equation
vMass ¼ vFeV  ½Fe þ vTissue  ð1 ½FeÞ; ð1Þ
where χTissue is the mass-specific magnetic susceptibility of non-
haem-iron-free spleen tissue and [Fe] is the tissue non-haem-iron
concentration expressed as the fraction of the mass of the tissue
that is non-haem-iron. Fits of this model to the data from eachFig. 3. Relationship between FS measured at 78 K (related to the fraction of
goethite-like iron oxyhydroxide in tissue) and FD measured at 5 K (related to the
fraction of non-crystalline iron oxyhydroxide in tissue) for β-thalassaemia (●)
and β-thalassaemia/Hb E (▲) spleen samples.
Fig. 4. Mass susceptibility of β-thalassaemia (●) and β-thalassaemia/Hb E (▲)
spleen tissue samples versus iron concentration.
Fig. 5. Distribution of iron-specific magnetic susceptibilities of β-thalassaemia
(●) and β-thalassaemia/Hb E (▲) spleen tissue samples (p-value of 0.01).
Fig. 6. Iron-specific magnetic susceptibility of β-thalassaemia (●) and β-
thalassaemia/Hb E (▲) spleen tissue samples versus non-haem FS measured at
78 K. (Spearman rank order correlation p-value 0.03).
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iron-specific magnetic susceptibilities (χ′Fe) of 1.10±0.10×
10− 6 m3/kgFe and 1.60±0.20×10
− 6 m3/kgFe and mass-specific
magnetic susceptibilities for non-haem-iron-free tissue (χTissue)
of−7.8±1.0×10− 9 m3/kg dry tissue and−7.9±1.3×10− 9 m3/kg
dry tissue for the transfusion-dependent β-thalassaemia and
non-transfusion-dependent β-thalassaemia/Hb E patients
respectively. It should be noted that the values of the
average non-haem-iron-specific magnetic susceptibilities
deduced from this model are based on the assumption that
there is no increase in concentration of other high magnetic
susceptibility elements concomitant with the non-haem-iron
concentration increases. The validity of this assumption is
supported by a previous study of macro, trace, and ultra-
trace elements in thalassaemic tissues [30].
The values for the mass-specific magnetic susceptibilities of
non-haem-iron-free tissue (χTissue) from the above analysis were
used to calculate a value of the non-haem-iron-specific magnetic
susceptibility (χFe) for each individual tissue specimen using the
following equation
vFe ¼ vTissue þ
vMass  vTissue
½Fe ð2Þ
The distributions of values of χFe for each patient group are
shown in Fig. 5. The mean (±standard deviation) of χFe
for spleens from the transfusion-dependent β-thalassaemia
patients was 1.16±0.25×10−6 m3/kgFe and from the non-
transfusion dependent β-thalassaemia/Hb E patients was
1.55±0.23×10− 6 m3/kgFe. The medians (and interquartile
ranges) of χFe were 1.16 (0.85–1.44)×10
− 6 m3/kgFe and 1.63
(1.36–1.75) ×10− 6 m3/kgFe for the β-thalassaemia and
β-thalassaemia/Hb E patients respectively. The distributions
of χFe for the two patient groups were significantly different
(W–M–W test p=0.01). A statistically significant correlation
was observed between χFe and tissue non-haem-iron concen-tration neither for each patient group alone nor for the two
groups combined.
Fig. 6 shows the values of χFe for each tissue specimen
plotted against FS. There is a statistically significant correlation
between χFe and FS (Spearman rank order correlation
coefficient −0.54, p=0.03) with higher values of FS yielding
generally lower values of χFe. Fig. 7 shows the values of χFe for
each tissue specimen plotted against FD. There is a statistically
significant correlation between χFe and FD (Spearman rank
order correlation coefficient 0.58, p=0.02) with higher values
of FD yielding generally higher values of χFe.
The iron-specific magnetic susceptibility of the pooled
human liver ferritin sample was measured by assuming that
Fig. 7. Iron-specific magnetic susceptibility of β-thalassaemia (●) and β-
thalassaemia/Hb E (▲) spleen tissue samples versus FD. (Spearman rank order
correlation p-value 0.02).
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component of ferritin is equivalent to the average mass-specific
magnetic susceptibilities of non-haem-iron-free spleen tissues
(χTissue) −7.8×10−9 m3 kg. It is worth noting that even a
reasonably large percentage error on the value of the mass-
specific magnetic susceptibility of the non-iron component of
ferritin has very little effect on the result obtained for the iron-
specific magnetic susceptibility of ferritin. The value of χFe for
the ferritin sample was found to be 1.14 (±0.11)×10− 6 m3 kg
Fe−1 which is consistent with the value of 1.33 (±0.02)×
10−6 m3 kg Fe−1 obtained for horse spleen ferritin [19] but is
significantly less than the value of 1.64 (±0.04)× 10−6 m3 kg
Fe−1 obtained by Shoden and Sturgeon [20] for human liver
ferritin.
Measurement of χFe for three duplicate samples of homo-
genised spleen tissue indicated an overall analytic variability of
approximately 9.6%.
4. Discussion
The spleen samples from the two groups of patients covered
a range of tissue non-haem-iron concentrations but the
distributions of non-haem-iron concentration in the two groups
were similar thus enabling comparisons to be made between the
two groups. In all cases the predominant form of iron in the
tissues was non-haem iron.
The Mössbauer spectra recorded for all of the tissues in this
study consisted of a central doublet characteristic of high-spin
Fe(III) superposed on a spectral sextet, the sextet being due to
magnetic-hyperfine-field splitting of the 57Fe nuclear energy
levels. Similar central doublet and sextet signals have been
observed in previous reports of Mössbauer spectra of human
tissues or extracts from human tissues [13,16,29,31–43]. On the
basis of these previous reports these spectral components can beidentified as being due to polynuclear iron(III) oxyhydroxide
deposits in the tissue. The assignment of these signals to
polynuclear iron(III) oxyhydroxide deposits is consistent with
the fact that the predominant form of iron found in iron loaded
tissues is usually haemosiderin [44]. The doublet component
observed in the spectrum at 78 K has parameters consistent with
(a) ferritin, (b) non-crystalline haemosiderin, (c) haemosiderin
based on the structure of the mineral ferrihydrite, or (d) the
doublet component associated with haemosiderin based on the
structure of the mineral goethite (the doublet component being
due to those haemosiderin particles with a smaller magnetic
anisotropy energy) [13,15,16]. As such it is not possible to
unambiguously identify the source of this signal and the signal
may be due to a combination of the above forms of iron.
However, the sextet component in the spectrum at 78 K can be
identified as being due to the presence of haemosiderin based on
the structure of the mineral goethite since this is the only form of
tissue iron deposit known to give a Mössbauer spectral sextet
component with these parameters at 78 K [33,34,45]. Similarly,
while the sextet component at 5 K can be associated with any or
all of ferritin, ferrihydrite based haemosiderin, and goethite-like
haemosiderin, the doublet component observed at 5 K can be
uniquely assigned to non-crystalline iron oxyhydroxide
[13,15,16]. However, it is possible to rank the different forms
of haemosiderin, goethite-like, ferrihydrite-like and non-crystal-
line iron oxyhydroxide, in order of decreasing crystallinity.
Hence, as discussed elsewhere [17], the significantly
different distributions of FS for the two groups of patients
indicate that the chemical speciation of iron is different between
the two groups with the transfusion dependent β-thalassaemia
patients having a greater fraction of their spleen iron in the form
of the goethite-like iron oxyhydroxide. In this study it has been
shown that the distributions of FD for the two groups of patients
are not significantly different indicating that the fraction of
spleen iron in the form of non-crystalline iron oxyhydroxide is
not significantly different for the two groups of patients.
The observed negative correlation and apparently non-linear
relationship between FS and FD suggests that pathological
conditions that favour the formation of goethite-like haemosi-
derin in spleen tissue hinder the formation of non-crystalline
iron oxyhydroxide deposits and vice versa.
The observed linear relationships between the mass-specific
magnetic susceptibility and tissue non-haem-iron concentration
(Fig. 4) confirm that magnetic susceptometry techniques can be
used to assess tissue non-haem-iron concentrations. However,
the fact that the chemical speciation of the non-haem-iron
appears to determine the non-haem-iron-specific magnetic
susceptibility of the tissue (Figs. 6 and 7) suggests that errors
in estimations of tissue non-haem-iron concentrations will in
some part be due to the biological variability of the chemical
speciation between different individuals. A likely explanation
for the negative correlation between χFe and FS (Fig. 6) is that
the goethite-like deposits associated with the sextet signal in the
Mössbauer spectra at 78 K are more crystalline (as determined
by electron diffraction measurements) and have larger particle
sizes than the other forms of iron(III) oxyhydroxide tissue
deposits [25]. As such, there is likely to be a greater degree of
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reducing χFe. Similar arguments can be made to explain the
positive correlation between χFe and FD (Fig. 7). The doublet
component in the Mössbauer spectra at 5 K is associated with
non-crystalline iron(III) oxyhydroxide tissue deposits [25] and
hence these deposits are expected to have a greater fraction of
uncompensated spins in their structures thus increasing χFe.
The data presented in this report are for spleen tissue.
However, the organ of primary interest in the clinical use of
biomagnetic susceptometry is the liver. It is currently unknown
whether there is a similar magnitude of variation in the chemical
speciation of tissue iron deposits in iron loaded liver tissue. Four
liver samples reported in a previous study [17] (from the group
of non-transfusion dependent β-thalassaemia/Hb E patients)
gave values of FS in the approximate narrow range 0.08 to 0.14.
No data are available for transfusion dependent β-thalassaemia
liver tissue. Samples of pancreas tissue from three non-
transfusion dependent β-thalassaemia/Hb E patients did show
a somewhat larger variation in FS between individuals (range
from 0.12 to 0.27) [17]. The coefficient of variation of χFe for
all spleen specimens studied here was 21% (somewhat larger
than the average analytical uncertainty on the measurement of
χFe for an individual specimen of approximately 10%)
suggesting that biological variability in χFe would contribute a
random uncertainty of approximately 19% to non-invasive
measurements of spleen non-haem-iron concentrations using
biomagnetic susceptometry. If the currently accepted value of
χFe for use in liver biosusceptometry (1.6×10
−6 m3/kgFe) was
used to measure spleen iron concentration in the entire group of
patients in this study, there would be a systematic under-
estimation of the tissue non-haem-iron concentration of 12.5%
(SE 6%).
Further measurements of χFe for liver tissue specimens will
need to be made in order to determine whether similar
magnitudes of uncertainty would apply to biomagnetic
susceptometry measurements of liver iron concentration.
Differences in the iron-specific magnetic susceptibilities χFe
for liver tissue between different patients would explain some of
the variability seen in comparisons of measurements of liver
iron concentration measured by non-invasive magnetic mea-
surements with those measured by chemical assay of biopsy
specimens.
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